TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/12 14:21 | 11/6/12 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Richard Kelli | CA | O | Chief Ac | S | -305 | 49.19 | 0 | -6 | -53 | 5 | D | ||||||||||||||
12/14/10 17:54 | 12/13/10 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Richard Kelli | CA | O | Chief Ac | S.d | -414 | 53.08 | 0 | -8 | -56 | 6 | D | ||||||||||||||
12/14/10 17:52 | 12/13/10 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Richard Kelli | CA | O | Chief Ac | S.d | -399 | 53.18 | 0 | -8 | -55 | 6 | D | ||||||||||||||
12/7/09 20:15 | 12/3/09 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Richard Kelli | CA | O | Chief Ac | S.d | -764 | 50.91 | 0 | -15 | -94 | 1 | D | ||||||||||||||
5/5/09 17:17 | 5/4/09 | LIFE | Life Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Richard Kelli | CA | O | Chief Ac | S | -46 | 36.96 | 0 | -1 | -57 | 1 | D | ||||||||||||||
8/27/07 17:18 | 8/24/07 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Richard Kelli | CA | O | Chief Ac | S | -73 | 78.43 | 0 | -1 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |